Predictors of the Acceptance of an Electronic Coach Targeting Self-management of Patients With Type 2 Diabetes: Web-Based Survey.

Technology Acceptance Model eCoach mobile health self-management type 2 diabetes

Journal

JMIR formative research
ISSN: 2561-326X
Titre abrégé: JMIR Form Res
Pays: Canada
ID NLM: 101726394

Informations de publication

Date de publication:
16 Aug 2022
Historique:
received: 05 11 2021
accepted: 24 05 2022
revised: 29 04 2022
entrez: 16 8 2022
pubmed: 17 8 2022
medline: 17 8 2022
Statut: epublish

Résumé

Type 2 diabetes (T2D) is a lifestyle-related disease whose prevalence increases with age. Diabetes self-management through mobile health (mHealth) apps enables patients with T2D to improve their health. According to the Technology Acceptance Model (TAM), technology acceptance (ie, intended use) is necessary to ensure mHealth can be implemented successfully. Therefore, the specific acceptance requirements of patients with T2D should be considered. This cross-sectional study aims to examine the extent to which different TAM predictors are associated with the acceptance of a diabetes app including an electronic coach (eCoach; Iris app) among patients with T2D. Using a web-based survey, data on 92 patients with T2D (mean age 62.76 years, SD 8.29 years) were collected. Acceptance of the Iris app with the TAM predictors (ie, perceived usefulness, perceived ease of use, social influence, perceived self-efficacy, perceived security, prior usage experience, perceived health, and propensity of data/information sharing) was assessed. Further, control variables (ie, gender, age, education, ethnicity, household, BMI, amount of years with diabetes, diabetes-related complaints, and medication use) were assessed. Multiple linear regression analyses showed that acceptance of the Iris app was positively associated with perceived usefulness (β=.57, P<.001), social influence (subjective norm; β=.20, P=.004), and willingness to share data (β=.25, P<.001). In addition, acceptance regarding the Iris app was higher among patients with T2D with overweight (β=.23, P=.01) or obese BMI (β=.21, P=.01). The model explained 75.8% of the variance in the acceptance of the Iris app by patients with T2D. In addition, perceived usefulness of the Iris app was positively related to perceived ease of use (β=.32, P<.001), subjective norm (β=.26, P=.004), perceived control (β=.19, P=.03), willingness to share data (β=.20, P=.01) regarding the Iris app, and perceived security regarding general use of apps/smartphone/internet (β=.15, P=.04). The model explained 58.2% of the variance in patients' perceived usefulness about the Iris app. Among patients with T2D, the belief that the use of the Iris app is helpful/beneficial, the willingness to share their Iris app data, and others' approval of using this app can stimulate the acceptance of this app. In addition, the belief that the use of (health) apps is reliable and secure, the belief that the use of the Iris app is easy to use, a higher perceived capability and personal control with using this app, the willingness to share their Iris app data, and others' approval of using this app can stimulate the perceived usefulness of such an app. These TAM predictors explained a high variance in acceptance and perceived usefulness of the Iris app. Implications for practice are addressed.

Sections du résumé

BACKGROUND BACKGROUND
Type 2 diabetes (T2D) is a lifestyle-related disease whose prevalence increases with age. Diabetes self-management through mobile health (mHealth) apps enables patients with T2D to improve their health. According to the Technology Acceptance Model (TAM), technology acceptance (ie, intended use) is necessary to ensure mHealth can be implemented successfully. Therefore, the specific acceptance requirements of patients with T2D should be considered.
OBJECTIVE OBJECTIVE
This cross-sectional study aims to examine the extent to which different TAM predictors are associated with the acceptance of a diabetes app including an electronic coach (eCoach; Iris app) among patients with T2D.
METHODS METHODS
Using a web-based survey, data on 92 patients with T2D (mean age 62.76 years, SD 8.29 years) were collected. Acceptance of the Iris app with the TAM predictors (ie, perceived usefulness, perceived ease of use, social influence, perceived self-efficacy, perceived security, prior usage experience, perceived health, and propensity of data/information sharing) was assessed. Further, control variables (ie, gender, age, education, ethnicity, household, BMI, amount of years with diabetes, diabetes-related complaints, and medication use) were assessed.
RESULTS RESULTS
Multiple linear regression analyses showed that acceptance of the Iris app was positively associated with perceived usefulness (β=.57, P<.001), social influence (subjective norm; β=.20, P=.004), and willingness to share data (β=.25, P<.001). In addition, acceptance regarding the Iris app was higher among patients with T2D with overweight (β=.23, P=.01) or obese BMI (β=.21, P=.01). The model explained 75.8% of the variance in the acceptance of the Iris app by patients with T2D. In addition, perceived usefulness of the Iris app was positively related to perceived ease of use (β=.32, P<.001), subjective norm (β=.26, P=.004), perceived control (β=.19, P=.03), willingness to share data (β=.20, P=.01) regarding the Iris app, and perceived security regarding general use of apps/smartphone/internet (β=.15, P=.04). The model explained 58.2% of the variance in patients' perceived usefulness about the Iris app.
CONCLUSIONS CONCLUSIONS
Among patients with T2D, the belief that the use of the Iris app is helpful/beneficial, the willingness to share their Iris app data, and others' approval of using this app can stimulate the acceptance of this app. In addition, the belief that the use of (health) apps is reliable and secure, the belief that the use of the Iris app is easy to use, a higher perceived capability and personal control with using this app, the willingness to share their Iris app data, and others' approval of using this app can stimulate the perceived usefulness of such an app. These TAM predictors explained a high variance in acceptance and perceived usefulness of the Iris app. Implications for practice are addressed.

Identifiants

pubmed: 35972769
pii: v6i8e34737
doi: 10.2196/34737
pmc: PMC9428778
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e34737

Informations de copyright

©Zeena Harakeh, Hilde Van Keulen, Koen Hogenelst, Wilma Otten, Iris M De Hoogh, Pepijn Van Empelen. Originally published in JMIR Formative Research (https://formative.jmir.org), 16.08.2022.

Références

J Diabetes Sci Technol. 2017 Sep;11(5):1015-1027
pubmed: 28560898
Diabetes Res Clin Pract. 2017 Sep;131:70-81
pubmed: 28692830
Front Endocrinol (Lausanne). 2018 Jan 22;8:381
pubmed: 29403436
Ergonomics. 2014;57(5):635-52
pubmed: 24655221
NPJ Digit Med. 2021 Oct 5;4(1):144
pubmed: 34611287
Diabetes Care. 2013 Apr;36(4):1033-46
pubmed: 23468086
Diabetologia. 2019 Jun;62(6):877-887
pubmed: 30963188
J Med Internet Res. 2020 Sep 4;22(9):e18080
pubmed: 32624465
JMIR Mhealth Uhealth. 2017 Dec 06;5(12):e177
pubmed: 29212629
J Med Internet Res. 2014 Apr 09;16(4):e104
pubmed: 24718852
J Adv Nurs. 1999 Aug;30(2):352-9
pubmed: 10457237
Ned Tijdschr Geneeskd. 2017;160:D673
pubmed: 28098041
J Med Internet Res. 2019 Aug 13;21(8):e15023
pubmed: 31411146
Appl Clin Inform. 2018 Jul;9(3):604-634
pubmed: 30112741
Med 2 0. 2015 Mar 02;4(1):e1
pubmed: 25733033
J Am Med Inform Assoc. 2009 Jul-Aug;16(4):550-60
pubmed: 19390112
Int J Med Inform. 2011 Dec;80(12):e189-202
pubmed: 21956003
Health Informatics J. 2021 Jan-Mar;27(1):1460458220976737
pubmed: 33438494
Int J Med Inform. 2014 Mar;83(3):210-24
pubmed: 24388129
Health Qual Life Outcomes. 2013 Aug 13;11:138
pubmed: 23937988
BMC Health Serv Res. 2015 Feb 21;15:71
pubmed: 25885110
Curr Diabetes Rev. 2021;17(3):268-279
pubmed: 32682380
J Med Internet Res. 2012 Oct 01;14(5):e133
pubmed: 23026508
JMIR Mhealth Uhealth. 2017 Mar 01;5(3):e4
pubmed: 28249834

Auteurs

Zeena Harakeh (Z)

Department of Child Health, TNO, Netherlands Organization for Applied Scientific Research, Leiden, Netherlands.

Hilde Van Keulen (H)

Department of Child Health, TNO, Netherlands Organization for Applied Scientific Research, Leiden, Netherlands.

Koen Hogenelst (K)

Department of Training and Performance Innovations, TNO, Netherlands Organization for Applied Scientific Research, Soesterberg, Netherlands.

Wilma Otten (W)

Department of Child Health, TNO, Netherlands Organization for Applied Scientific Research, Leiden, Netherlands.

Iris M De Hoogh (IM)

Department of Microbiology and Systems Biology, TNO, Netherlands Organization for Applied Scientific Research, Zeist, Netherlands.

Pepijn Van Empelen (P)

Department of Child Health, TNO, Netherlands Organization for Applied Scientific Research, Leiden, Netherlands.

Classifications MeSH